ABIOMED Inc

Healthcare
$381.02
+0.23(0.06%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$380.78$381.0220,612,2572,131,045

Fundamentals

Market Cap$17.18B
P/B Ratio11.2
P/E Ratio64.4
Enterprise Value$16.99B
Div. Yield0.00%
Book Value33.94
EPS(TTM)2.34
ROENA
Understand Fundamentals

About the Company

Since its inception in 1981, Abiomed Inc. has introduced advanced and beneficial technologies for patients and physicians alike. It is a pioneer and global leader in the healthcare industry. The company has its headquarters in Massachusetts, USA, with offices in various locations around the globe, including two in Germany and one in Japan. Abiomed was founded with a motive to develop the first artificial human heart. The company accomplished this goal and introduced AbioCor, the world’s first completely self-contained, implantable artificial heart. It was successfully transplanted to a patient in 2001. Subsequently, more such transplants were carried out. On September 5th 2006, this device received approval from the Food and Drugs Administration (FDA). In 2005, the company acquired Impella CardioSystems AG of Germany, maker of Impella – the world’s smallest heart pump. With this acquisition, its focus shifted from heart replacement to recovery. These devices are available in a variety of ranges, with some of them receiving FDA approvals in the US. Times Magazine awarded AbioCor the Best Invention of the Year award in 2001. The company ranked 64 among the 2000 Global Growth Champions list by Forbes in 2018. It was also added to the S&P 500 index in this same year. In 2019, Abiomed ranked 19th on the Fortune magazine’s list of 100 fastest-growing companies. It held the 4th position in Barron’s ranking of the best-performing stocks of the 2010s. Furthermore, on 25th March 2020, Abiomed announced its strategies to aid the global medical community and improved patient care during Covid-19 outbreak. Abiomed Inc. is a leading provider of circulatory support to patients. It engages in research, development and sale of medical devices catering to the care of patients with heart issues. Its products are designed to assist a failing heart, thus improving the blood flow. Over years, Abiomed has remained dedicated in serving the global healthcare community through sincere efforts and a mission of ‘recovering hearts and saving lives’.;
OrganisationABIOMED Inc
IndustryMedical Devices
HeadQuartersDanvers, MA

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ